These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2103203)

  • 1. [Panic attack secondary to the oral administration of a sustained-release preparation of theophylline].
    Marcos Sánchez F; Gómez Tello V; Celdrán Gil J; Durán Pérez-Navarro A
    An Med Interna; 1990 Jan; 7(1):53. PubMed ID: 2103203
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anxiety crisis (panic attack) secondary to the administration of theophylline in an oral sustained-release preparation].
    Gea J; de Pablo J; Martí J; Picado C; Pujol A; Agustí-Vidal A
    Rev Clin Esp; 1988 Oct; 183(5):280. PubMed ID: 3212257
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
    Brown DL; Maddux MS; Organek HW; Bauman JL
    Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of oral sustained-release capsules of theophylline.
    Schaaf LJ
    Ann Allergy; 1979 Oct; 43(4):259-60. PubMed ID: 555605
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma theophylline concentrations following the oral administration of microcrystalline theophylline and a new sustained-release theophylline preparation to normal subjects.
    Russell CJ; Elwood RK; Kinney C; McDevitt DG
    Eur J Clin Pharmacol; 1980 Oct; 18(4):351-4. PubMed ID: 7439257
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative bioavailability of 2 oral theophylline sustained-release preparations].
    Tritthart W; Lücker PW; Fáy E; Buchebner J
    Arzneimittelforschung; 1983; 33(11):1603-6. PubMed ID: 6686457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euphylong. A new sustained-release theophylline pellet formulation for once-daily evening administration.
    Arzneimittelforschung; 1988 Aug; 38(8A):1199-256. PubMed ID: 3190807
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The bioavailability of 4 sustained-release theophylline preparations from the Chilean market].
    Biagini L; Zamora P; Chávez H; Saavedra I
    Rev Med Chil; 1990 Nov; 118(11):1241-6. PubMed ID: 2152650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
    Nolte D; Dusik B
    Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M; Rondanelli R; Vidale E; Cristiani D
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the pharmacokinetics of theophylline in asthmatic patients following multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Yamaki K; Satake T; Hasegawa T; Ogura Y; Suzuki R; Mizukami Y
    Arerugi; 1985 Nov; 34(11):1006-14. PubMed ID: 4084062
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects.
    Bialer M; Salame K; Raz I
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):662-7. PubMed ID: 4093206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
    Nolte D; Dusik B
    Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparison of a slow-release theophylline-hydroxyzine combination and a plain slow-release theophylline preparation.
    Tukiainen H; Silvasti M; Karttunen P; Savolainen K; Kokkonen P; Parviainen M
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):346-50. PubMed ID: 3209282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.